NEW YORK (GenomeWeb) − A year after launching its targeted sequencing method as a service, Dutch startup Cergentis has automated the technology and launched reagent kits for its protocols. In the near future, the firm plans to introduce an updated version of the method, called targeted locus amplification (TLA), and intends to outlicense it to service providers and diagnostic laboratories.
Cergentis Plans Update, New Kits for Targeted Resequencing Method; Seeks Partners for Outlicensing
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Browse our free articlesYou can still register for access to our free content.